Related Experiment Video

Updated: Oct 9, 2025

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

HLA-DRB1*03:190, a novel HLA-DRB1 allele suspected with microlymphocytoxicity and confirmed by sequencing

Francoise Bonneville¹, Orane Calvo De Olmos¹, Gaelle Blanchet¹

¹Histocompatibility and Immunogenetics laboratory, Etablissement Français du Sang Centre-Pays de la Loire, Nantes, France.

|December 21, 2021

Abstract:

The novel HLA-DRB1*03:190 allele was characterized using two next generation sequencing technologies.

Keywords:

HLA-DRB1*03:190 HLA NGS novel HLA allele

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

HLA-C*01:224N, a novel null HLA-C allele characterized by two next-generation sequencing methods.

HLA·2022

Characterization of the novel HLA-B*55:122 allele by two next-generation sequencing methods.

HLA·2021

Characterization of the novel HLA-DRB1*11:296 allele by two next-generation sequencing methods.

HLA·2021

Characterization of the novel HLA-C*06:346 allele by two next-generation sequencing methods.

HLA·2021

Characterization of the novel HLA-A*01:406 allele by two next generation sequencing methods.

HLA·2021

Characterization of the novel HLA-A*01:405 allele by two next generation sequencing methods.

HLA·2021

See all related articles